0001209191-12-059482.txt : 20121227
0001209191-12-059482.hdr.sgml : 20121227
20121227161914
ACCESSION NUMBER: 0001209191-12-059482
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20121226
FILED AS OF DATE: 20121227
DATE AS OF CHANGE: 20121227
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Cassella James V
CENTRAL INDEX KEY: 0001353528
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-51820
FILM NUMBER: 121287623
MAIL ADDRESS:
STREET 1: 2091 STIERLIN COURT
CITY: MOUNTAIN VIEW
STATE: CA
ZIP: 94043
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Alexza Pharmaceuticals Inc.
CENTRAL INDEX KEY: 0001344413
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 770567768
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2091 STIERLIN COURT
CITY: MOUNTAIN VIEW
STATE: CA
ZIP: 94043
BUSINESS PHONE: 650.944.7000
MAIL ADDRESS:
STREET 1: 2091 STIERLIN COURT
CITY: MOUNTAIN VIEW
STATE: CA
ZIP: 94043
4
1
c30873_4x0.xml
MAIN DOCUMENT DESCRIPTION
X0306
4
2012-12-26
0001344413
Alexza Pharmaceuticals Inc.
ALXA
0001353528
Cassella James V
ALEXZA PHARMACEUTICALS INC.
2091 STIERLIN COURT
MOUNTAIN VIEW
CA
94043
0
1
0
0
EVP, R&D and CSO
Common Stock
2012-12-26
4
S
0
4558
4.8959
D
950
D
Represents shares issued as restricted stock units (an "RSU") under the Issuer's 2005 Equity Incentive Plan that vested in full on December 21, 2012. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 25, 2012.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.77 to $4.99, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
/s/ Brent D. Fassett, Attorney-in-Fact
2012-12-27